TC BioPharm has announced a General Meeting (GM) of shareholders to be held on March 14, 2024, at 2:00 p.m. UK time, at the company's registered office in Holytown, Motherwell. The meeting will address two ordinary resolutions: the authorization to adjourn the GM if necessary to permit further solicitation of proxies, and the authorization to issue securities in one or more non-public offerings in accordance with Nasdaq Marketplace Rule 5635(d). The latter is a strategic move to raise additional capital up to $4 million, which the company indicates is necessary to fund operations and implement its business strategy. The Board of Directors unanimously recommends shareholders vote in favor of the resolutions, emphasizing their alignment with the company's best interests. Shareholders registered by March 12, 2024, are entitled to vote, and those holding American Depositary Shares (ADSs) must submit their voting instructions by March 8, 2024. The GM notice includes detailed voting procedures and the Board's rationale for the proposed resolutions, highlighting the potential impact on the company's capital structure and governance.

TC BioPharm has announced a General Meeting (GM) of shareholders to be held on March 14, 2024, at 2:00 p.m. UK time, at the company's registered office in Holytown, Motherwell. The meeting will address two ordinary resolutions: the authorization to adjourn the GM if necessary to permit further solicitation of proxies, and the authorization to issue securities in one or more non-public offerings in accordance with Nasdaq Marketplace Rule 5635(d). The latter is a strategic move to raise additional capital up to $4 million, which the company indicates is necessary to fund operations and implement its business strategy. The Board of Directors unanimously recommends shareholders vote in favor of the resolutions, emphasizing their alignment with the company's best interests. Shareholders registered by March 12, 2024, are entitled to vote, and those holding American Depositary Shares (ADSs) must submit their voting instructions by March 8, 2024. The GM notice includes detailed voting procedures and the Board's rationale for the proposed resolutions, highlighting the potential impact on the company's capital structure and governance.